Archive for the 'launch' tag
February 8th, 2013 by Dr. Samuel Dyer
Crash diets can be all the rage but quickly fade...
Read morePosted in Pharma Industry Business News | No comments
January 22nd, 2013 by Dr. Samuel Dyer
Takeda Pharmaceutical Company Limited...
Read morePosted in Breaking World Pharma News, Pharma Industry Business News | No comments
December 6th, 2012 by Dr. Samuel Dyer
Roche (SIX: RO, ROG; OTCQX: RHHBY) and the...
Read morePosted in Breaking World Pharma News | No comments
December 6th, 2012 by Dr. Samuel Dyer
Roche (SIX: RO, ROG; OTCQX: RHHBY) and the...
Read morePosted in Breaking World Pharma News | No comments
December 3rd, 2012 by Dr. Samuel Dyer
Clostridium difficile infection (CDI), a...
Read morePosted in Clinical Trial Results, Pharma Industry Business News | No comments
July 25th, 2012 by Dr. Samuel Dyer
Boston, MA, July 24, 2012— PAREXEL...
Read morePosted in Clinical Trial Results | No comments
July 25th, 2012 by Dr. Samuel Dyer
Boston, MA, July 24, 2012— PAREXEL...
Read morePosted in Clinical Trial Results | No comments
June 19th, 2012 by Dr. Samuel Dyer
BOSTON, June 18 , 2012 /PRNewswire/ —...
Read morePosted in Clinical Trial Results | No comments
May 24th, 2012 by Dr. Samuel Dyer
GlaxoSmithKline and AstraZeneca welcomed the...
Read morePosted in Breaking World Pharma News, Pharma Industry Business News | No comments
May 9th, 2012 by Dr. Samuel Dyer
The Cancer Support Community (CSC) and the Amgen...
Read morePosted in Breaking World Pharma News, Pharma Industry Business News | No comments
May 2nd, 2012 by Dr. Samuel Dyer
Savient?( $SVNT ) is grappling with a...
Read morePosted in Pharma Industry Business News | No comments
March 26th, 2012 by Dr. Samuel Dyer
By Sten Stovall AstraZeneca has given investors...
Read morePosted in Business of Health, Pharma Industry Business News | No comments
March 15th, 2012 by Dr. Samuel Dyer
A 40-year career at Johnson & Johnson ( $JNJ...
Read morePosted in Pharma Industry Business News | No comments
March 5th, 2012 by Dr. Samuel Dyer
European antitrust police are dropping another...
Read morePosted in Pharma Industry Business News | No comments
March 4th, 2012 by Dr. Samuel Dyer
Eli Lilly and Company (NYSE:LLY) announced the...
Read morePosted in Breaking World Pharma News | No comments
February 9th, 2012 by Dr. Samuel Dyer
Get your canvases, paintbrushes and cameras ready...
Read morePosted in Breaking World Pharma News | No comments
November 10th, 2011 by Dr. Samuel Dyer
H. Lundbeck A/S (Lundbeck) reports third quarter...
Read morePosted in Breaking World Pharma News | No comments
November 10th, 2011 by Dr. Samuel Dyer
H. Lundbeck A/S (Lundbeck) reports third quarter...
Read morePosted in Breaking World Pharma News | No comments
September 28th, 2011 by Dr. Samuel Dyer
Eli Lilly and Company (NYSE: LLY) announced the...
Read morePosted in Breaking World Pharma News | No comments
August 24th, 2011 by Dr. Samuel Dyer
eurocancercoms has announced the launch of...
Read morePosted in Breaking World Pharma News | No comments
July 10th, 2011 by Dr. Samuel Dyer
As part of a three-year global initiative to...
Read morePosted in Breaking World Pharma News | No comments
June 16th, 2011 by Dr. Samuel Dyer
Genzyme, a Sanofi company (EURONEXT: SAN and...
Read morePosted in Breaking World Pharma News | No comments
March 3rd, 2011 by Dr. Samuel Dyer
As part of its ongoing mission to serve cancer...
Read morePosted in Breaking World Pharma News | No comments
February 28th, 2011 by Dr. Samuel Dyer
Genzyme Corporation (NASDAQ: GENZ) recognized...
Read morePosted in Breaking World Pharma News | No comments
February 28th, 2011 by Dr. Samuel Dyer
Genzyme Corporation (NASDAQ: GENZ) recognized...
Read morePosted in Breaking World Pharma News | No comments
Older